-+ 0.00%
-+ 0.00%
-+ 0.00%

XTL Biopharmaceuticals Announces The Appointment Of Noam Band As The Company's New CEO; Shlomo Shalev Will Continue As The Chairman Of The Board Of Directors

Benzinga·04/07/2025 13:28:33
Listen to the news

Brings a Wealth of Managerial Experience and Track Record

RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL") announced today the appointment of Noam Band as the Company's new Chief Executive Officer. Shlomo Shalev will continue as the Chairman of the Board of Directors.

Previously, Mr. Band has served as the Chairman and Chief Executive Officer of Gix Internet Ltd. (formerly Algomizer Ltd.) (TASE:GIX), a publicly traded technology company specializing in online marketing, and as the Chief Executive Officer of Dotomi (acquired by ValueClick), where he oversaw operations and strategic initiatives in the digital marketing space. From 2020 through its acquisition in 2023 he served as a board advisor to 7digital Group plc (formerly AIM: 7DIG), contributing to its strategic direction and corporate governance. He has also served as the

Chief Executive Officer of Monitor2Heart He holds an MBA and a B.A. in Economics from The Hebrew University of Jerusalem.